Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEHAB-II: Penile Rehabilitation After Prostatectomy
NCT06875258Phase 4Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jan 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sildenafil in erectile dysfunction (ED) (2 arms), sponsored by Netherlands Cancer Institute. Primary endpoint: Adequate unassisted erection sufficient for successful sexual intercourse without medication or devices at 24 months. Started Jan 2024; status: recruiting.
02
Drugs
sildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06875258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06875258.